Distribution and kinetics of lipoprotein-bound lipoteichoic acid

Infection and Immunity

Volumn 71, Issue 6, 2003, Pages 3280-3284

  Levels, Johannes H M ^a   Abraham, Philip R ^a   Van Barreveld, Erik P ^a   Meijers, Joost C M ^a   Van Deventer, Sander J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; IMMUNOSTIMULATING AGENT; LIPOPROTEIN; LIPOTEICHOIC ACID; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BACTERIAL CELL WALL; BINDING AFFINITY; BINDING KINETICS; CELLULAR DISTRIBUTION; FLUORESCENCE; GEL PERMEATION CHROMATOGRAPHY; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TEMPERATURE DEPENDENCE;

HUMANS; KINETICS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; TEICHOIC ACIDS; TEMPERATURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038104808     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.6.3280-3284.2003     Document Type: Article

References (31)

1. Alvarez, C., and A. Ramos. 1986. Lipids, lipoproteins and apoproteins in serum during infection. Clin. Chem. 32:142-145.
2. Bhakdi, S., T. Klonisch, P. Nuber, and W. Fischer. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59:4614-4620.
3. Cabana, V. G., J. N. Siegel, and S. M. Sabesin. 1989. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J. Lipid Res. 30:39-49.
4. De Kimpe, S. J., M. Kengatharan, C. Thiemermann, and J. R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA 92:10359-10363.
5. 125I-LPS to plasma proteins from persons with high of low HDL. Scand. J. Clin. Lab. Investig. 56:533-543.
6. Emancipator, K., G. Sako, and R. J. Elin. 1992. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect. Immun. 60:596-601.
7. Fischer, W., H. U. Koch, and R. Haas. 1983. Improved preparation of lipoteichoic acids. Eur. J. Biochem. 133:523-530.
8. Flegel, W. A., A. Wölpl, H. Northhoff, and D. N. Männel. 1989. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect. Immun. 57:2237-2245.
9. Flo, T. H., O. Halaas, E. Lien, L. Ryan, G. Teti, D. T. Golenbock, A. Sundan, and T. Espevik. 2000. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164:2064-2069.
10. Fraunberger, P., S. Schaefer, K. Werdan, A. K. Walli, and D. Seidel. 1999. Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin. Chem. Lab. Med. 37:357-362.
11. Gordon, B. R., T. S. Parker, D. M. Levine, S. D. Saal, J. C. L. Wang, B. J. Sloan, P. S. Barie, and A. L. Rubin. 1996. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit. Care Med. 24:584-589.
12. Grunfeld, C., and K. R. Feingold. 1996. Regulation of lipid metabolism by cytokines during host defence. Nutrition 12:24-26.
13. Grunfeld, C., M. Marshall, J. K. Shigenaga, A. H. Moser, P, Tobias, and K. R. Feingold. 1999. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J. Lipid Res. 40:245-252.
14. Heumann, D. 2001. CD14 and LBP in endotoxemia and infections caused by gram-negative bacteria. J. Endotoxin Res. 7:439-441.
15. Krieger, M. 1999. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoproteins receptor SR-BI. Annu. Rev. Biochem. 68:523-558.
16. Levels, J. H. M., P. R. Abraham, A. van den Ende, and S. J. H. van Deventer. 2001. Distribution and kinetics of lipoprotein-bound endotoxin. Infect. Immun. 68:2821-2828.
17. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193:393-397.
18. Morath, S., A. Geyer, I. Spreitzer, C. Hermann, and T. Hartung. 2002. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70:938-944.
19. Munford, R. S., and J. M. Dietschy. 1985. Effects of specific antibodies, hormones and lipoproteins on bacterial lipopolysaccharides injected into rat. J. Infect. Dis. 152:177-184.
20. Qureshi, N., K. Takayama, P. Mascagni, J. Honovich, R. Wong, and R. J. Cotter. 1988. Complete structural determination of lipopolysaccharide obtained from deep rough mutant of Escherichia coli. J. Biol. Chem. 263:11971-11976.
21. Roth, R. I., F. C. Levin, and J. Levin. 1993. Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin. Infect. Immun. 61:3209-3215.
22. Tobias, P., K. Soldau, and R. Ulevitch. 1989. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J. Biol. Chem. 264:10867-10871.
23. Triantafilou, K., M. Triantafilou, and R. L. Dedrick. 2001. Interactions of bacterial lipopolysaccharide and peptidoglycan with a 70 kDa and an 80 kDa protein on the cell surface of CD14+ and CD14-cells. Hum. Immunol. 62:50-63.
24. Underhill, D. M., and A. Ozinsky. 2002. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14:103-110.
25. Underhill, D. M., A. Ozinsky, A. M. Hajjar, A. Stevens, C. B. Wilson, M. Bassetti, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosome and discriminates between pathogens. Nature 401:811-815.
26. Van Lenten, B. J., A. M. Fogelman, M. E. Haberland, and P. A. Edwards. 1986. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA 83:2704-2708.
27. Vesy, C. J., R. L. Kitchens, G. Wolfbauer, J. J. Albers, and R. S. Munford. 1999. Lipopolysaccharide-binding protein and phospholipid transferprotein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68:2410-2417.
28. Wetering, J. K., M. Eijk, L. M. G. van Golde, T. Hartung, J. A. van Strijp, and J. J. Batenburg. 2001. Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria. J. Infect. Dis. 184:1143-1151.
29. Wurfel, M. M., E. Hailman, and S. D. Wright. 1995. Soluble CD14 acts as a shuttle in the neutralization of LPS by LPS-binding protein and reconstituted high density lipoprotein. J. Exp. Med. 181:1743-1754.
30. Wurfel, M. M., and S. D. Wright. 1997. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers. J. Immunol. 158:3925-3934.
31. Yu, B., and S. D. Wright. 1996. Catalytic properties of lipopolysaccharide (LPS) binding protein. J. Biol. Chem. 271:4100-4105.